Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial

OBJECTIVE: The use of gonadotropin-releasing hormone agonist (GnRHa) as an alternative for human chronic gonadotropin (hCG) trigger has potential benefits, but the optimal luteal phase support (LPS) following GnRHa trigger remains to be elucidated. We aimed to investigate a new strategy (daily GnRH...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehpour, Saghar, Nazari, Leila, Hosseini, Sedighe, Azizi, Elham, Borumandnia, Nasrin, Hashemi, Teibeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Assisted Reproduction 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312295/
https://www.ncbi.nlm.nih.gov/pubmed/33507722
http://dx.doi.org/10.5935/1518-0557.20200077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312295/
https://www.ncbi.nlm.nih.gov/pubmed/33507722
http://dx.doi.org/10.5935/1518-0557.20200077

Ejemplares similares